For informational purposes only.
Dalfampridine Extended Release Tablet
Dalfampridine is a potassium channel blockers.
Dalfampridine tablet is prescribed to adults for multiple sclerosis (MS).
Dalfampridine Tablets Uses :-
Dalfampridine tablet is used for the treatment of adults for multiple sclerosis (MS).
Dalfampridine improves walking speed and walking in adults with multiple sclerosis (MS). and controls the symptoms of multiple sclerosis. Dalfampridine may be used alone or in combination with other medicines.
Dalfampridine Tablets Dosage Forms & Strengths :-
Dalfampridine Tablets Dosage :-
Dalfampridine Tablets Sideeffects :-
Insomnia,
Dizziness,
Headache,
Getting nausea,
Weakness,
Back pain,
Problems with balance,
Multiple sclerosis relapse,
Skin irritation,
Tingling or itching,
Nose and throat irritation,
How Dalfampridine works:-
Dalfampridine -
Precautions :-
Tell your doctor if you have kidney disease.
Pregnant or planning to become pregnant. It is unknown whether dalfampridine will harm the unborn baby. This your doctor will decide.
Breastfeeding women. It is unknown whether dalfampridine passes into breast milk. It will be up to you and your doctor to decide whether you should take dalfampridine or breast-feed.
If you have a seizure while taking dalfampridine, stop taking dalfampridine and tell your doctor right away. You may have a seizure while taking dalfampridine,
Even if you've never had a stroke before. If you take too much dalfampridine you may have a mild decrease in kidney function, which is normal after the age of 50, making seizures more likely. For this your doctor may do a blood test to check this.
Dalfampridine should not be taken with 4-aminopyridine (4-AP, fampridine), as its constituents are similar.
Dalfampridine can cause serious side effects with severe allergic reactions. Such as difficulty in breathing, swelling of the tongue or throat and hives etc. If these symptoms occur, you should stop taking dalfampridine and seek help from your doctor.
Classification :-
Habit Forming - No
Drug - Dalfampridine
Therapeutic Class - Potassium Channel Blockers
Information on this page was last updated on 09 September 2021